Acadia knows the sales but the onus is on Neuren to know anything relating to safety.
If this FDA approved drug gets into a controversy, it may affect approval across the world and impacts rest of the world licensing royalties Neuren stands to make to the tune of US$300+ million.
- Forums
- ASX - General
- Its Over
Its Over, page-20245
-
- There are more pages in this discussion • 2,518 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)